Advertisement
U.S. Markets open in 9 hrs 1 min

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.1500-0.0600 (-4.96%)
At close: 04:00PM EST
1.1501 +0.00 (+0.01%)
After hours: 07:49PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2100
Open1.2400
Bid1.1000 x 100
Ask1.1800 x 100
Day's Range1.1050 - 1.2400
52 Week Range1.1050 - 2.2600
Volume169,265
Avg. Volume43,417
Market Cap20.564M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.2100
Earnings DateNov 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.67
  • GlobeNewswire

    UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates

    SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2024. “As recently discussed on our Ophthalmology Day for investors and analysts, diabetic macular edema represents a large underserved market due to inadequate response to anti-VEGF standard of care, continued vision los

  • GlobeNewswire

    UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024

    SAN FRANCISCO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that it will host an in-person and virtual event for investors and analysts on Tuesday, October 15, 2024, at 8:00 a.m. ET in New York, NY. The event will feature presentations from prominent ophthalmology key opinion leaders (KOLs) and company management. UNITY Biotechnology Ophthalmology D